Posts With Tag NASDAQ AQST

Discover crucial updates from Aquestive Therapeutics, Inc. in their 8-K filing on February 12, 2025, detailing significant events and stock information. Stay informed!

Explore the latest 8-K filing from Aquestive Therapeutics, Inc. revealing crucial corporate changes as of January 13, 2025, impacting investors and stakeholders.

Explore the significant events disclosed in Aquestive Therapeutics' 8-K report filed on December 19, 2024. Essential insights for investors regarding stock performance and operations.